Under the terms of the agreement, Roche Pharma will gain access to all the features of the CNS subset of the DrugTarget Database(TM). These include informatics on more than 3,400 genes, 886 comprehensive immunohistochemistry (IHC) reports with localization information on more than 450 potential drug targets selected by pharmaceutical company subscribers, and innovative search and analysis tools. LifeSpan continues to build the database by publishing localization data on an undisclosed number of additional protein targets each year.
Friday, February 2, 2007
LifeSpan BioSciences & Roche
Agreement details here:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment